Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1345-1355

  Romani, Luigina ^a   Mencacci, Antonella ^a   Cenci, Elio ^a   Spaccapelo, Roberta ^a   Toniatti, Carlo ^b   Puccetti, Paolo ^c   Bistoni, Francesco ^a   Poli, Valeria ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRBM   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANDIDIASIS; CONTROLLED STUDY; FEMALE; HELPER CELL; HOST RESISTANCE; LEUKOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY; LYMPHOCYTE ACTIVATION; MICE; NEUTRALIZATION TESTS; NEUTROPHILS; STOMACH; TH1 CELLS; TH2 CELLS;

EID: 0029913685     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1345     Document Type: Article

References (55)

1. Hirano, T., and T. Kishimoto. 1990. Interleukin-6. In Handbook of Experimental Pharmacology. M.B. Sporn and A.B. Roberts, editors. Springer-Verlag KG, Heidelberg, Germany. 632-665.
2. Taga, T., and T. Kishimoto. 1992. Cytokine receptors and signal transduction. FASEB (Fed. Am. Soc. Exp. Biol.) J. 6: 3387-3396.
3. Breen, E.C., A.R. Rezai, K. Nakajima, G.N. Beall, R.T. Mitsuyasu, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:480-484.
4. Wong, S.Y., M.H. Beaman, J.S. Abrams, and J.S. Remington. 1992. Kinetics of IFN-γ and IL-6 secretion in murine toxoplasmosis. Proc. Intl. Conf. Antimicrobial Agents and Chemotherapy. Abstr. 330. p. 166.
5. Yoshimoto, T., K. Nakanishi, S. Hirose, K. Hiroishi, H. Okamura, Y. Takemoto, A. Kanamaru, T. Hada, T. Tamura, E. Kakishita, and K. Higashino. 1992. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/ tumor necrosis factor. J. Immunol. 148:3596-3603.
6. Havell, E.A., and P.B. Sehgal. 1991. Tumor necrosis factor-independent IL-6 production during murine listeriosis. J. Immunol. 146:756-761.
7. Suzuki, Y., Q. Yang, F.K. Conley, J.S. Abrams, and J.S. Remington. 1994. Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect. Immun. 62:2773-2778.
8. Fletcher Starnes, J.R.H., M.K. Pearce, A. Tewari, J.H. Yim, J.-C. Zou, and J.S. Abrams. 1990. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis-α challenge in mice. J. Immunol. 145: 4185-4191.
9. Liu, Z., R.J. Simpson, and C. Cheers. 1994. Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes. J. Immunol. 152:5375-5380.
10. Heremans, H., C. Dillen, W. Put, J.V. Damma, and A. Billiau. 1992. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin associated with paradoxically increased IL-6 levels Eur. J. Immunol. 22:2395-2401.
11. Cohen, R., F.J. Roth, E. Delgado, D.G. Ahearn, and M.H. Kalser. 1969. Fungal flora of the normal human small and large intestine. N. Engl. J. Med. 280:638-641.
12. Meunier, F., H. Aoun, and N. Bitar. 1992. Candidemia in immunocompromised patients. Clin. Infect. Dis. 14(Suppl. 1P): S120-125.
13. Romani, L., P. Puccetti, and F. Bistoni. 1996. Biological role of helper T-cell subsets in candidiasis. Chem. Immunol. 63: 115-137.
14. Puccetti, P., L. Romani, and F. Bistoni. 1995. A Th1/Th2-like switch in candidasis: new perspectives for therapy. Trends Microbiol. 3:237-240.
15. Romani, L., A. Mencacci, U. Grohmann, S. Mocci, P. Mosci, P. Puccetti, and F. Bistom. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176:19-25.
16. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 upregulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152:3514-3521.
17. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J. Immunol. 150:925-931.
18. + subset expression in murine candidiasis. Infect. Immun. 60:4950-4952.
19. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S.F. Wolf, and F. Bistoni. 1994. Interleukin-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153: 5167-5175.
20. Spaccapelo, R., L. Romani, L. Tonnetti, E. Cenci, A. Mencacci, R. Tognellini, S.G. Reed, P. Puccetti, and F. Bistoni. 1995. TGF-β is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155:1349-1360.
21. Steinshamn, S., and A. Waage. 1992. Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice. Infect. Immun. 60:4003-4008.
22. Screpanti, I., L. Romani, P. Musiani, A. Modesti, E. Fattori, D. Lazzaro, C. Sellitto, S. Scarpa, D. Bellavia, G. Lattanzo, et al. 1995. Lymphoproliferative disorder and imbalanced T helper response in C/EBPβ deficient mice. EMBO (Eur. Mol. Biol. Organ.) J. 14:1932-1941.
23. Poli, V., R. Balena, E. Fattori, A. Markatos, M. Yamamoto, H. Tanaka, G. Ciliberto, G.A. Rodan, and F. Costantini. 1994. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO (Eur. Mol. Biol. Organ.) J. 13:1189-1196.
24. Robertson, E., A. Bradley, M. Kuehn, and M. Evans. 1986. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature (Lond.). 323:445-448.
25. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K.-H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171: 1279-1288.
26. Arcone, R., P. Pucci, F. Zappacosta, V. Fontaine, A. Malorni, G. Marino, and G. Ciliberto. 1991. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur. J. Biochem. 198:541-547.
27. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA. 83:9679-9683.
28. Cenci, E., L. Romani, A. Mencacci, R. Spaccapelo, E. Schiaffella, P. Puccetti, and F. Bistoni. 1993. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur. J. Immunol. 23:1034-1038.
29. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 22:909-915.
30. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenolchloroform extraction. Annal. Biochem. 162:156-159.
31. Saki, R.K., S. Scarf, F. Faloona, K.B. Mullis, G.T. Horn, H.A. Herlich, and N. Arnheim. 1985. Enzymatic amplification of γ-globulin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (Wash. DC). 230: 1350-1354.
32. Morawetz, R.A., M.T. Doherty, N.A. Giese, J.W. Hartley, W. Muller, R. Kuhn, K. Rajeswsky, R. Coffman, and H.C. Morse III. 1994. Resistance to murine acquired immunodeficiency syndrome (MAIDS). Science (Wash. DC). 265:264-267.
33. Beagley, K.W., J.H. Eldndge, F. Lee, H. Kiyono, M.P. Everson, W.J. Koopman, T. Hirario, T. Kishimoto, and J.R. McGhee. 1989. Interleukins and IgA synthesis: Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169:2133-2148.
34. Ramsay, A.J., A.J. Husband, I.A. Ramshaw, S. Bao, K.I. Matthaei, G. Koehler, and M Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science (Wash. DC). 264:561-563.
35. Cantorna, M.T., and E. Balish. 1990. Mucosal and systemic candidiasis in congenitally immunodeficient mice. Infect. Immun. 58:1093-1100.
36. Cole, G.T., K.T. Lynn, K.R. Seshan, and L.M. Pope. 1989. Gastrointestinal and systemic candidiasis in immunocompromised mice. J. Med. Vet. Mycol. 27:363-380.
37. Puccetti, P., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, K.-H. Enssle, L. Romani, and F. Bistoni. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1325-1331.
38. Liu, Z., R.J. Simpson, and C. Cheers. 1992. Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect. Immun. 60:4402-4406.
39. Birx, D.L., R.R. Redfield, K. Tencer, A. Fowler, D.S. Burke, and G. Tosato. 1990. Induction of IL-6 during human immunodeficiency virus infection. Blood. 76:2303-2310.
40. Dalrymple, S.A., L.A. Lucian, R. Slattery, T. McNeil, D.M. Hud, S. Fuchino, F. Lee, and R. Murray. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
41. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253-278.
42. Frei, K., U.V. Malipiero, T.P. Leist, R.M. Zinkernagel, M.E. Schwab, and A. Fontana. 1989. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:689-694.
43. Horii, Y., A. Maraguchi, M. Iwano, T. Matsuda, T. Hirayama, Y. Fuji, K. Dhi, H. Ishikawa, Y Ohmoto, K. Yoshizaki et al. 1989. Involvement of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. J. Immunol. 143:3949-3955.
44. + T helper cell subsets. Curr. Opin. Immunol. 5:391-397.
45. Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (Lond.). 368:339-341.
46. Libert, C., N. Takahashi, A. Cauwels, P. Brouckaert, H. Bluethmann, and W. Fiers. 1994. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur. J. Immunol. 24:2237-2242.
47. Fatton, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in interleukin 6-deficient mice. J. Exp. Med. 180:1243-1250.
48. Appelberg, R., A.G. Castro, J. Pedrosa, and P. Minoprio. 1994. Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology. 82: 361-364.
49. Rousset, F., E. Garcia, T. Defrance, C. Peronne, N. Vezzio, D.H. Hsu, R. Kastelein, K.W. Moore, and J. Banchereau. 1992. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA. 89:1890-1893.
50. D'Andrea, A., M. Aste-Arnezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
51. Hsieh, C.-S., S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181: 713-721.
52. Tonnetti, L., R. Spaccapelo, E. Cenci, A. Mencacci, P. Puccetti, R.L. Coffman, F. Bistoni, and L. Romani. 1995. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25:1559-1565.
53. Wong, G.G., J.S. Witek-Giannotti, P.A. Temple, R. Kriz, C. Ferenz, R.M. Hewick, S.C. Clark, K. Ikebuchi, and M. Ogawa. 1988. Stimulation of murine hemopoietic colony formation by human IL-6. J. Immunol. 140:3040-3044.
54. Ulich, T.R., K.Z. Guo, D. Remick, J. del Castillo, and S.M. Yin. 1991. Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J. Immunol. 146:2316-2323.
55. Borish, L., R. Rosenbaum, L. Albury, and S. Clark. 1989. Activation of neutrophils by recombinant interleukin 6. Cell. Immunol. 121:280-289.